World Diabetes Day: Prevention, Early Diagnosis, and Diagnostic Innovation

Today, on World Diabetes Day, the global community comes together to raise awareness about diabetes, a chronic and potentially disabling condition that, if not diagnosed and managed early, can lead to serious complications.

Type 1 diabetes is an autoimmune disease that typically develops in the first 10–20 years of life. Because it can often go unrecognized, early diagnosis is essential, particularly for children and young people.

Eurospital’s Role in Diabetes Diagnostics

In the effort to support diabetes prevention and early detection, Eurospital reaffirms its commitment to laboratories and healthcare professionals with innovative, scientifically validated diagnostic solutions.

DiabeGen I Step and DiabeGen II Step are Real-Time PCR molecular biology kits designed to assess genetic predisposition to type 1 diabetes, allowing identification of individuals at risk and supporting early intervention.

Thanks to these tools, Eurospital contributes concretely to improving early detection, facilitating timely diagnosis, and promoting personalized patient care.

A future with fewer diabetes-related complications is possible: prevention, early diagnosis, and high-quality diagnostics are key to achieving it.